Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 12, 1278-1285 (1 November 2006) | doi:10.1038/nm1498;
Activated protein C inhibits tissue plasminogen activator|[ndash]|induced brain hemorrhage
&
Abstract
Brain hemorrhage is a serious complication of tissue plasminogen activator (tPA) therapy for ischemic stroke. Here we report that activated protein C (APC), a plasma serine protease with systemic anticoagulant, anti-inflammatory and antiapoptotic activities, and direct vasculoprotective and neuroprotective activities, blocks tPA-mediated brain hemorrhage after transient brain ischemia and embolic stroke in rodents. We show that APC inhibits a pro-hemorrhagic tPA-induced, NF-κB–dependent matrix metalloproteinase-9 pathway in ischemic brain endothelium in vivo and in vitro by acting through protease-activated receptor 1. The present findings suggest that APC may improve thrombolytic therapy for stroke, in part, by reducing tPA-mediated hemorrhage.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).